Are you Dr. Cho?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1101 Nott St
Ellis Hospital Laboratory, Dept Of Pathology
Schenectady, NY 12308Phone+1 518-243-4050Fax+1 518-262-5861
Summary
- Dr. Daniel Cho, MD is a board certified pathologist in Schenectady, New York. He is currently licensed to practice medicine in New York and New Hampshire. He is affiliated with Ellis Medicine and is an Assistant Professor at New York Univ Sch of Med.
Education & Training
- Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 2007 - 2011
- Albany Medical CenterResidency, Urology, 2003 - 2007
- New York Presbyterian HospitalInternship, Transitional Year, 2001 - 2002
- State University of New York Downstate Medical Center College of MedicineClass of 2001
Certifications & Licensure
- NY State Medical License 2011 - 2026
- NH State Medical License 2023 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 11 citationsDifferential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review.Hua Li, Zhi-Yan Fu, Mustafa Erdem Arslan, Daniel Cho, Hwajeong Lee
World Journal of Experimental Medicine. 2021-12-30 - 27 citationsSafety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, Alexandra Drakaki, Ivor John Percent
Cancer. 2021-11-16 - 46 citationsBempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma.Adi Diab, Scott S. Tykodi, Gregory A. Daniels, Michele Maio, Brendan D. Curti
Journal of Clinical Oncology. 2021-07-13
Press Mentions
- Perlmutter Cancer Center Expands Clinical Trials ProgramApril 12th, 2019